Network integration of multi-tumour omics data suggests novel targeting strategies

33Citations
Citations of this article
108Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We characterize different tumour types in search for multi-tumour drug targets, in particular aiming for drug repurposing and novel drug combinations. Starting from 11 tumour types from The Cancer Genome Atlas, we obtain three clusters based on transcriptomic correlation profiles. A network-based analysis, integrating gene expression profiles and protein interactions of cancer-related genes, allows us to define three cluster-specific signatures, with genes belonging to NF-κB signaling, chromosomal instability, ubiquitin-proteasome system, DNA metabolism, and apoptosis biological processes. These signatures have been characterized by different approaches based on mutational, pharmacological and clinical evidences, demonstrating the validity of our selection. Moreover, we define new pharmacological strategies validated by in vitro experiments that show inhibition of cell growth in two tumour cell lines, with significant synergistic effect. Our study thus provides a list of genes and pathways that could possibly be used, singularly or in combination, for the design of novel treatment strategies.

Cite

CITATION STYLE

APA

do Valle, Í. F., Menichetti, G., Simonetti, G., Bruno, S., Zironi, I., Durso, D. F., … Remondini, D. (2018). Network integration of multi-tumour omics data suggests novel targeting strategies. Nature Communications, 9(1). https://doi.org/10.1038/s41467-018-06992-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free